# Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds

> **NCT01657292** · PHASE3 · COMPLETED · sponsor: **Birken AG** · enrollment: 61 (actual)

## Conditions studied

- Burns

## Interventions

- **DRUG:** Oleogel-S10 ointment
- **DEVICE:** Octenilin® wound gel

## Key facts

- **NCT ID:** NCT01657292
- **Lead sponsor:** Birken AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-07
- **Final completion:** 2014-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657292, "Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01657292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*